• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    11/14/24 5:26:24 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care
    Get the next $RVP alert in real time by email
    false 0000946563 0000946563 2024-11-14 2024-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) November 14, 2024

     

    Retractable Technologies, Inc.

    (Exact name of registrant as specified in its charter)

     

    Texas 001-16465 75-2599762
    (State or other jurisdiction (Commission (IRS Employer
    of incorporation) File Number) Identification No.)

     

    511 Lobo Lane, Little Elm, Texas 75068-5295
    (Address of principal executive offices) (Zip Code)

     

    Registrant's telephone number, including area code (972) 294-1010

     

    None

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock RVP NYSE American

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      Emerging growth company  ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 8.01Other Events.

     

    On November 14, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing results for the periods ended September 30, 2024.

     

    Item 9.01Financial Statements and Exhibits.

     

    (d)  Exhibits

     

    99Press release announcing results for the periods ended September 30, 2024.

     

    104Cover Page Interactive Date File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    DATE: November 14, 2024 RETRACTABLE TECHNOLOGIES, INC.
      (Registrant)
         
      BY: /s/ John W. Fort III
        JOHN W. FORT III
        VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER

     

     

     

    Get the next $RVP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RVP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Retractable Technologies, Inc. Announces Reduction in Workforce

      Retractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 7%. The reduction is expected to save an estimated $1.6 million in annual wages and benefits, or approximately 7.8% of total estimated workforce costs. The expected savings is offset by one-time separation payments of approximately $300 thousand to the affected workers. Approximately 72% of the targeted payroll reduction affects general and administrative functions, with the remainder coming from manufacturing or manufacturing support positions. The move comes as the Company continues to allocate more of its resources to increase its U.S. manufacturing capabilities and reduce reliance on pr

      4/10/25 5:34:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Reports Results for 2024

      Retractable Technologies, Inc. (NYSE:RVP) reports the following information relating to the year ended December 31, 2024. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 28, 2025 with the U.S. Securities and Exchange Commission. The Company's revenues for 2024 decreased 24.2%. The Company's revenues were approximately $33.0 million in 2024 as compared to approximately $43.5 million in the prior year. Domestic revenues decreased 15.1% principally due to a decrease in the average selling price as a result of product mix, combined with higher transactional and order fulfillment costs with its distributors. I

      3/28/25 4:58:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

      3/28/25 4:53:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • PRESIDENT AND CEO Shaw Thomas J bought $6,063 worth of shares (8,113 units at $0.75), increasing direct ownership by 0.05% to 15,261,367 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/9/25 3:39:01 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $296 worth of shares (400 units at $0.74), increasing direct ownership by 0.00% to 15,253,254 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/8/25 11:44:13 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $3,367 worth of shares (4,500 units at $0.75), increasing direct ownership by 0.03% to 15,252,854 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/7/25 11:46:27 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    SEC Filings

    See more
    • Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      4/11/25 2:12:43 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      3/28/25 5:02:43 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K filed by Retractable Technologies Inc.

      10-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      3/28/25 3:13:44 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • PRESIDENT AND CEO Shaw Thomas J bought $6,063 worth of shares (8,113 units at $0.75), increasing direct ownership by 0.05% to 15,261,367 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/9/25 3:39:01 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $296 worth of shares (400 units at $0.74), increasing direct ownership by 0.00% to 15,253,254 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/8/25 11:44:13 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $3,367 worth of shares (4,500 units at $0.75), increasing direct ownership by 0.03% to 15,252,854 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/7/25 11:46:27 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      2/8/23 2:38:31 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      5/2/22 4:33:55 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      1/27/22 2:27:52 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Financials

    Live finance-specific insights

    See more
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

      3/28/25 4:53:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2024 through December 31, 2024. The dividends will be paid on January 20, 2025 to shareholders of record as of the close of business on January 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

      12/30/24 12:59:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024 to shareholders of record as of the close of business on October 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV

      9/30/24 3:46:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Leadership Updates

    Live Leadership Updates

    See more
    • Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

      LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Conv

      1/8/21 2:32:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care